PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 40.10% | -49.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 40.10% | -49.92% | |||
| Cost of Revenue | 26.44% | -46.22% | |||
| Gross Profit | 97.30% | -61.10% | |||
| SG&A Expenses | -15.47% | 1.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.56% | -37.02% | |||
| Operating Income | 152.12% | -232.34% | |||
| Income Before Tax | 144.80% | -236.50% | |||
| Income Tax Expenses | 125.24% | -245.27% | |||
| Earnings from Continuing Operations | 155.87% | -231.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 155.87% | -231.99% | |||
| EBIT | 152.12% | -232.34% | |||
| EBITDA | 181.34% | -192.91% | |||
| EPS Basic | 155.85% | -231.83% | |||
| Normalized Basic EPS | 146.88% | -223.47% | |||
| EPS Diluted | 155.85% | -231.83% | |||
| Normalized Diluted EPS | 146.88% | -223.47% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||